|
LOC550643 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.957800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.426000E-02 |
| Normal-vs-Stage2 |
3.018700E-03 |
| Normal-vs-Stage3 |
4.086800E-01 |
| Normal-vs-Stage4 |
3.175600E-01 |
| Stage1-vs-Stage2 |
2.856800E-01 |
| Stage1-vs-Stage3 |
3.620300E-02 |
| Stage1-vs-Stage4 |
2.132400E-02 |
| Stage2-vs-Stage3 |
8.838600E-03 |
| Stage2-vs-Stage4 |
7.859100E-03 |
| Stage3-vs-Stage4 |
7.145000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.694100E-02 |
| Normal-vs-AfricanAmerican |
4.032800E-01 |
| Normal-vs-Asian |
5.980400E-02 |
| Caucasian-vs-AfricanAmerican |
4.187000E-01 |
| Caucasian-vs-Asian |
9.278100E-02 |
| AfricanAmerican-vs-Asian |
1.199410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.903840E-03 |
| Normal-vs-Female |
2.351200E-01 |
| Male-vs-Female |
8.19520000000518E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.345000E-01 |
| Normal-vs-Extreme_Weight |
2.240300E-02 |
| Normal-vs-Obese |
9.485700E-02 |
| Normal-vs-Extreme_Obese |
1.697970E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.090300E-02 |
| Normal_Weight-vs-Obese |
9.510300E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.394640E-01 |
| Extreme_Weight-vs-Obese |
6.036600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.407600E-01 |
| Obese-vs-Extreme_Obese |
4.596000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.944600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.673200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.523900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.654400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.617200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.074200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.081600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.979500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.643800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.849800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.038170E-02 |
| Normal-VS-Type2 PRCC |
3.163800E-01 |
| Normal-VS-KIRP CIMP |
9.920700E-03 |
| Normal-VS-Unclassified PRCC |
1.436180E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.448200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.377080E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.972780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.950100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.566200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.27210000000233E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.341820E-01 |
| Normal-vs-N1 |
1.528950E-01 |
| Normal-vs-N2 |
9.958400E-02 |
| N0-vs-N1 |
1.572330E-02 |
| N0-vs-N2 |
1.460620E-03 |
| N1-vs-N2 |
1.139770E-01 |
|
|
